ONABOTULINUMTOXINA IS WELL TOLERATED IN CHRONIC MIGRAINE PATIENTS TAKING ORAL PREVENTIVE MEDICATIONS: LONG-TERM COMPEL ANALYSIS BY TREATMENT CYCLE

被引：0
|
作者：
Winner, Paul K. [1 ]
Blumenfeld, Andrew M. [2 ]
Eross, Eric J. [3 ]
Orejudos, Amelia [4 ]
Adams, Aubrey Manack [4 ]
Brin, Mitchell F. [4 ,5 ]
机构：
[1] Palm Beach Headache Ctr, Premiere Res Inst Palm Beach Neurol, W Palm Beach, FL USA
[2] Headache Ctr Southern Calif, Neurol Ctr, Carlsbad, CA 92011 USA
[3] Phoenix Headache Inst, Scottsdale, AZ USA
[4] Allergan Plc, Irvine, CA USA
[5] Univ Calif Irvine, Irvine, CA USA
来源：
TOXICON | 2018年 / 156卷
关键词：
Adverse events; Chronic migraine; COMPEL; Concomitant medication; OnabotulinumtoxinA; Safety;
D O I：
10.1016/j.toxicon.2018.11.274
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
264
引用
收藏
页码：S114 / S114
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of onabotulinumtoxinA for the prophylaxis of headaches in adult chronic migraine patients: an interim analysis of the prospective, long-term, multicenter, open-label study, COMPEL
    Blumenfeld, A.
    Stark, R.
    Reppine, A.
    Halstead, M.
    Holdbrook, F.
    Adams, A. Manack
    Aurora, S.
    JOURNAL OF PAIN, 2015, 16 (04): : S92 - S92
  • [22] ANALYSIS OF PATTERNS OF RESPONSE TO ONABOTULINUMTOXINA IN CHRONIC MIGRAINE IN PREDICTING LONG-TERM OUTCOME
    Ahmed, F.
    Khalil, M.
    Tanvir, T.
    Buture, A.
    CEPHALALGIA, 2018, 38 : 87 - 88
  • [23] Analysis of patterns of response to OnabotulinumtoxinA in Chronic Migraine in predicting long-term outcome
    Buture, Alina
    Ghabeli, Ali J.
    Khalil, Modar
    Ahmed, Fayyaz
    CEPHALALGIA, 2017, 37 : 113 - 114
  • [24] Analysis of patterns of response to OnabotulinumtoxinA in Chronic Migraine in predicting long-term outcome
    Ahmed, Fayyaz
    Buture, Alina
    Tanvir, Taukir
    Khalil, Modar
    CEPHALALGIA, 2019, 39 : 259 - 260
  • [25] Adherence to oral migraine-preventive medications among patients with chronic migraine
    Hepp, Zsolt
    Dodick, David W.
    Varon, Sepideh F.
    Gillard, Patrick
    Hansen, Ryan N.
    Devine, Emily B.
    CEPHALALGIA, 2015, 35 (06) : 478 - 488
  • [26] OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
    Guerzoni, Simona
    Cainazzo, Maria Michela
    Pini, Luigi Alberto
    JOURNAL OF HEADACHE AND PAIN, 2015, 16
  • [27] Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
    Navarro-Perez, Maria Pilar
    Gonzalez-Quintanilla, Vicente
    Munoz-Vendrell, Albert
    Madrigal, Elisabet
    Alpuente, Alicia
    Latorre, German
    Molina, Francis
    Monzon, Maria Jose
    Medrano, Vicente
    Garcia-Azorin, David
    Gonzalez-Oria, Carmen
    Gago-Veiga, Ana
    Velasco, Fernando
    Beltran, Isabel
    Morollon, Noemi
    Viguera, Javier
    Casas-Limon, Javier
    Rodriguez-Vico, Jaime
    Cuadrado, Elisa
    Irimia, Pablo
    Iglesias, Fernando
    Guerrero-Peral, angel Luis
    Belvis, Robert
    Pozo-Rosich, Patricia
    Pascual, Julio
    Santos-Lasaosa, Sonia
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [28] Cortical excitability in chronic migraine patients after OnabotulinumtoxinA preventive treatment
    Shevchenko, Vladlena
    Artemenko, Ada
    Bzhiljanski, Mikhail
    Bushkov, Fedor
    Yahno, Nikolay
    Kurenkov, Alexey
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [29] Long-term experience with onabotulinumtoxina in the treatment of chronic migraine: lessons after one year
    Pascual, J.
    Ramon, C.
    Larrosa, D.
    Riesco, N.
    Alvarez, R.
    Cernuda-Morollon, E.
    CEPHALALGIA, 2015, 35 : 54 - 54
  • [30] Preventive pharmacotherapy of migraine long-term treatment
    Manzoni, GC
    CONFINIA CEPHALALGICA, 1995, 4 (04): : 113 - 114
12345